Alterations in cardiac autonomic neuronal function have become the foc
us of intense research in various cardiovascular diseases. Both single
-photon emission tomography (SPECT) and the positron emission tomograp
hy (PET) imaging techniques in combination with radiolabeled neurotran
smitters and receptor ligands have become available for the scintigrap
hic visualization of presynaptic and postsynaptic neuronal function. S
everal clinical studies have shown changes in tracer distribution in d
ifferent clinical conditions, such as ischemic heart disease, congesti
ve heart failure, malignant arrhythmias, heart transplantation, and in
patients with diabetes. In patients with congestive heart failure, pr
evious in vitro investigations have concentrated on the postsynaptic l
evel of the sympathetic innervation. However, alterations in presynapt
ic nerve function have been demonstrated with scintigraphic investigat
ions by decreased presynaptic tracer retention. Moreover, correlation
between scintigraphic findings and clinical outcome was shown in patie
nts with heart failure, providing important prognostic information sup
erior to conventional risk assessment. In conclusion, scintigraphic ev
aluation by SPECT and PET allows functional characterization of cardia
c presynaptic and postsynaptic neurons. Regional tracer uptake can be
used as an index for the integrity of innervation in various diseases.
Newer tracer approaches may allow the noninvasive quantification of n
euronal function by PET.